Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study
BackgroundCardiovascular disease (CVD) remains a major contributor to the global disease burden. Previous studies have established a link between the atherogenic index of plasma (AIP) and CVD. However, it remains unclear whether cumulative AIP and AIP control influence the future incidence of CVD in...
Saved in:
Main Authors: | Yu Zhang, Yue Song, Yinfei Lu, Tao Liu, Ping Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1517658/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The kidney reabsorption-related magnesium depletion score is associated with cardiovascular disease and longitudinal mortality in diabetic kidney disease patients
by: Zhengxi Zhou, et al.
Published: (2025-01-01) -
Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study
by: Yaohua Hu, et al.
Published: (2025-01-01) -
Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study
by: Gaoshu Zheng, et al.
Published: (2025-01-01) -
A lower atherogenic index of plasma was associated with a higher incidence of sarcopenia
by: Zhiping Duan, et al.
Published: (2025-01-01) -
Association of the triglyceride glucose index with all cause and CVD mortality in the adults with diabetes aged < 65 years without cardiovascular disease
by: Chang Liu, et al.
Published: (2025-01-01)